Clinical Trials Logo

Allergic Rhinitis clinical trials

View clinical trials related to Allergic Rhinitis.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT06267261 Completed - Allergic Rhinitis Clinical Trials

Efficacy of Face Mask in Reducing Respiratory Allergic Symptoms in Birch-allergic Subjects in ALYATEC Exposure Chamber

Start date: June 7, 2021
Phase: N/A
Study type: Interventional

There is no clinical evidence that face masks are efficient in birch pollen-induced asthma. As the use of face masks has become widespread worldwide to limit the spread of SARS-CoV-2, this study aims to demonstrate the clinical efficacy of medical masks in patients allergic to birch in the same way that clinical trial with drugs.

NCT ID: NCT06051786 Completed - Allergic Rhinitis Clinical Trials

A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergic Rhinitis

Start date: August 20, 2020
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of Azelastine HCl-Fluticasone propionate Nasal Spray 137-50 mcg/spray compared to Dymista™ in patients with perennial allergic rhinitis

NCT ID: NCT05956691 Completed - Allergic Rhinitis Clinical Trials

AllerPops Reduce Nasal Symptoms in Adult Volunteers With Allergic Rhinitis

Start date: April 5, 2022
Phase: Phase 2
Study type: Interventional

The goal of this clinical trial is to test AllerPops' effectiveness in people who suffer from allergic rhinitis. The main question[s]it aims to answer are: 1. To assess the effectiveness of AllerPops on relieving nasal symptoms compared to the control group in volunteers with seasonal/year-long allergies during the first 7 days of the 21-day intervention period. 2. To evaluate the safety of AllerPops administration in volunteers with seasonal/year-long allergies during a 21-day intervention period. Up to 30 days between Screening (V1) and Baseline (V2), and a 21-day intervention period, with dosing occurring every other day for a minimum of 3 doses, and thereafter until the participant is satisfied with the relief of the nasal allergy symptoms. The suitable season for the trial will be determined based on the seasonal variation measures. Researchers will compare slow and fast consuming groups to see if the way of use impact the effectiveness.

NCT ID: NCT05912192 Completed - Allergic Rhinitis Clinical Trials

The Efficacy Of Elonide Nasal Corticosteroids In Managing Allergic Rhinitis

Start date: February 24, 2022
Phase: N/A
Study type: Interventional

The aim of this clinical study is to compare the efficacy of Elonide Nasal Spray to Nasonex Nasal Spray and Placebo (non-active ingredient) in the management of allergic rhinitis. There are two hypotheses of this study: 1. Elonide nasal spray is same efficacy to Nasonex nasal spray. 2. Elonide nasal spray is more efficient to placebo.

NCT ID: NCT05870644 Completed - Allergic Rhinitis Clinical Trials

Acute Effects of Exercise at Different Temperatures in Allergic Rhinitis Patient

Start date: August 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the effects of exercise at different temperatures on nasal blood flow and symptoms in allergic rhinitis patients.

NCT ID: NCT05779046 Completed - Allergic Rhinitis Clinical Trials

Acute Effect of High Intensity Interval Exercise in Patients With Allergic Rhinitis

Start date: September 10, 2022
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the acute effect of high intensity interval exercise on respiratory function and rhinitis symptoms in allergic rhinitis patients.

NCT ID: NCT05753241 Completed - COVID-19 Clinical Trials

the Relationship Between Allergic Rhinitis and the Risk of Symptom in Patients With Mild COVID-19

Start date: November 10, 2022
Phase:
Study type: Observational [Patient Registry]

At present, most studies mainly focussed on severe patients, and there was no comparison of symptom differences between AR patients and healthy people with mild infection to evaluate the symptoms of AR patients during infection and to provide preventive treatment in advance. So this experiment was designed.

NCT ID: NCT05709977 Completed - Allergic Rhinitis Clinical Trials

Acupuncture for Nasal Congestion in Allergic Rhinitis

ANCAR
Start date: April 20, 2023
Phase: N/A
Study type: Interventional

Allergic rhinitis (AR) is a disorder that affects more than 500 million people worldwide. Nasal congestion is one of the most general and bothersome symptoms in rhinitis, which affects the quality of life (QOL). Current medications are undesirable due to their side-effects. Acupuncture for AR in general can be considered as safe and can be seen as a potential therapeutic intervention for nasal congestion. Evidence supported that acupuncture is clinically used for signs and symptoms of nose disorders, such as nasal congestion, with effectiveness, but whether acupuncture has immediate, post-treatment and long-term effects on nasal congestion in AR is not verified by strictly designed clinical study. The ANCAR trial uses a standard treatment protocol with a fixed set of acupuncture points - to be as scientific as possible from Western medical viewpoint - to open the nose and affect underlying energetic imbalance and immunity at the same time, to maintain its nose opening effect. This novel acupuncture treatment protocol can be seen as a solid and profound approach from which every AR patient may benefit.

NCT ID: NCT05707611 Completed - Allergic Rhinitis Clinical Trials

Acute Effects of Various Aerobic Exercise in Allergic Rhinitis.

Start date: August 1, 2020
Phase: N/A
Study type: Interventional

This study was to investigate the comparison among acute effects of various aerobic exercise on symptoms in allergic rhinitis patients.

NCT ID: NCT05693883 Completed - Allergic Rhinitis Clinical Trials

Pilates Training in Patients With Allergic Rhinitis

Start date: February 15, 2021
Phase: N/A
Study type: Interventional

The purpose of this study was to determine the effects of pilates training on symptoms in patients with allergic rhinitis.